Literature DB >> 18977672

Tumor-specific immune responses.

Hans Schreiber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18977672      PMCID： PMC3644555          DOI： 10.1016/j.smim.2008.10.001

Source DB:  PubMed          Journal:  Semin Immunol        ISSN： 1044-5323            Impact factor:   11.130


× No keyword cloud information.
  15 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

Review 2.  The concept of immunological surveillance.

Authors:  F M Burnet
Journal:  Prog Exp Tumor Res       Date:  1970

3.  Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations.

Authors:  B S Worley; L T van den Broeke; T J Goletz; C D Pendleton; E M Daschbach; E K Thomas; F M Marincola; L J Helman; J A Berzofsky
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

4.  Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

Authors:  Gerald Willimsky; Thomas Blankenstein
Journal:  Nature       Date:  2005-09-01       Impact factor: 49.962

Review 5.  Technology insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies.

Authors:  Rajiv Khanna; Denis Moss; Maher Gandhi
Journal:  Nat Clin Pract Oncol       Date:  2005-03

Review 6.  Unique tumor antigens redefined as mutant tumor-specific antigens.

Authors:  D Mumberg; M Wick; H Schreiber
Journal:  Semin Immunol       Date:  1996-10       Impact factor: 11.130

7.  A unique tumor antigen produced by a single amino acid substitution.

Authors:  P A Monach; S C Meredith; C T Siegel; H Schreiber
Journal:  Immunity       Date:  1995-01       Impact factor: 31.745

8.  Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.

Authors:  C Van Waes; P A Monach; J L Urban; R D Wortzel; H Schreiber
Journal:  Tissue Antigens       Date:  1996-05

9.  Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.

Authors:  P L Ward; H Koeppen; T Hurteau; H Schreiber
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

10.  Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness.

Authors:  Gerald Willimsky; Melinda Czéh; Christoph Loddenkemper; Johanna Gellermann; Karin Schmidt; Peter Wust; Harald Stein; Thomas Blankenstein
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307
View more
  1 in total

1.  A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs).

Authors:  Jennifer D Stone; David H Aggen; Andrea Schietinger; Hans Schreiber; David M Kranz
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.